Skip to main content
Therma Bright Inc. logo

Therma Bright Inc. — Investor Relations & Filings

Ticker · THRM ISIN · CA8834262070 LEI · 529900PN7P0GSORO2174 TSXV Manufacturing
Open in API
Filings indexed 525 across all filing types
Latest filing 2020-09-15 Capital/Financing Update
Country CA Canada
Listing TSXV THRM

About Therma Bright Inc.

https://www.thermabright.com/

Therma Bright Inc. is a medical technology company that develops, acquires, and markets proprietary diagnostic and medical device technologies for the consumer and institutional healthcare sectors. The company's portfolio addresses key areas including pain management, circulation, diagnostics, and critical care. Core products and development projects include Venowave, a medical device designed to boost circulation and prevent blood clots; the Digital Cough Test (DCT), an AI-powered application developed with AI4LYF for rapid, non-invasive detection of respiratory diseases; and the PREVA™ clot retriever, developed with Inretio for enhanced thrombectomy procedures in ischemic stroke treatment. Furthermore, Therma Bright is advancing inhaled statin therapy in partnership with InVixa for the treatment of COVID-19 pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 85% confidence The document is a press release providing a development update on a COVID-19 rapid saliva test by Therma Bright and Orpheus Medica. It discusses progress in research, regulatory discussions with Health Canada, and future plans for the product. There are no financial statements, no detailed financial performance data, no regulatory filings or certifications, and no mention of shareholder meetings or voting results. The content is an update on product development and regulatory status, typical of a Capital/Financing Update or general corporate update. However, since it focuses on development progress and regulatory approval process rather than fundraising or capital structure changes, it fits best under Capital/Financing Update (CAP) as it relates to development progress and regulatory pathway which impacts financing and capital deployment. The document length is 6631 characters, which is substantive but not a full financial report. Therefore, the classification is CAP with high confidence.
2020-09-15 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the identification of novel biological detection molecules for a COVID-19 rapid test by Therma Bright and Orpheus Medica. It contains no financial data, no regulatory filings, no voting results, no management changes, no earnings or interim reports, no audit information, and no capital or financing updates. It is a corporate announcement about product development and research progress. The document is not a report itself but a news announcement about a scientific development. Therefore, it does not fit into any of the specific financial or regulatory filing categories. The best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories. The confidence in this classification is high given the clear nature of the document as a press release about product development.
2020-09-03 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and includes a detailed corporate update from Therma Bright Inc. It discusses recent developments such as further testing of technology, product redesign, asset acquisition, and joint development agreements. The document is a formal disclosure of a material change as required by Canadian securities regulations (NI 51-102). It is not a full financial report, earnings release, or management discussion but rather a regulatory filing announcing a material corporate update. The length (9758 characters) and content indicate it is not a brief announcement but a substantive material change report. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-09-02 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a corporate update press release from Therma Bright Inc. It provides information on product testing, redesign, relaunch plans, and joint development agreements. There are no financial statements, earnings data, or detailed financial analysis present. The document is informational and forward-looking but does not constitute a formal financial report or regulatory filing. It is not an earnings release, annual or interim report, or any other formal filing type. The content fits best as a general regulatory announcement or corporate update. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2020-09-01 English
Material change report - English.pdf
Regulatory Filings
2020-08-27 English
News release - English.pdf
Regulatory Filings
2020-08-27 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.